ClinicalTrials.govcontrolled
Phase I Study of MK-0683 in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-098)
ClinicalTrials.gov study NCT00858234. IPD Sharing: YES. Countries: 0. Publications: 1.
ShareScore
32/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 8
- Harmonization
- 12
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 8